Treatment trends of cutaneous leishmaniasis in Saudi Arabia

Saudi Medical Journal

Volumn 26, Issue 8, 2005, Pages 1220-1224

  Al Jaser, May H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM;

ABDOMINAL PAIN; AGE DISTRIBUTION; ARTICLE; CRYOTHERAPY; DEMOGRAPHY; DIARRHEA; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ELECTROSTIMULATION THERAPY; ENDEMIC DISEASE; ETHNOLOGY; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEART ARRHYTHMIA; HUMAN; IMMUNE SYSTEM; NAUSEA; PAIN; PRACTICE GUIDELINE; QUESTIONNAIRE; SAUDI ARABIA; SIDE EFFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME; VOMITING; WORLD HEALTH ORGANIZATION;

HUMANS; LEISHMANIASIS, CUTANEOUS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SAUDI ARABIA;

EID: 24744466752     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol 1996; 14: 417-423.
2. Desjeux P. Leishmaniasis: current situation and new prospectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305-318.
3. Peters W. Royal Society of Tropical Medicine and Hygiene presidential address. Manson House, 15 October 1987. "The little sister"-a tale of Arabia. Trans R Soc Trop Med Hyg 1988; 82: 179-184.
4. Peters W, Al-Zahrani MA. The leishmaniasis - a common health problem in Saudi Arabia. Saudi Med J 1987; 8: 333-343.
5. Hawary GH. Studies on cutaneous leishmaniasis in Central Region of Saudi Arabia from 1972-1975. Proceeding of the Medical Symposium in Leishmaniasis; 1980 March 22-24; Dammam, KSA. KSA: Ministry of Health; 1980. p. 73-78.
6. Bassiouny A. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol 1983; 109: 617-618.
7. Bassiouny A, El-Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmanaisis. Br J Dermatol 1982; 107: 467-474.
8. Kellum RE. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam). J Am Acad Dermatol 1986; 15: 620-622.
9. Pace JL. Cutaneous leishmaniasis. Arc Dermatol 1982; 118: 880.
10. Pace JL. Dose rifampicin have a place in the treatment of cutaneous leishmaniasis? Proceeding of the Medical Symposium in Leishmaniasis; 1980 March 22-24, Dammam, KSA. KSA: Ministry of Health; 1980. p. 126-136.
11. Pareek SS. Combination therapy of sodium stibogluconate and rifampicin in cutaneous leishmaniasis. Int J Dermatol 1984; 23: 70-71.
12. Al-Gindan Y, Abdul-Aziz O, Kubba R. Cutaneous leishmaniasis in Al-Hassa, Saudi Arabia. Int J Dermatol 1984; 23: 194-197.
13. Irajhi AA, Ibrahim EA, De Voln EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891-895.
14. Rahim GF, Tatar IH. Oriental sore in Iraq. Bull Endem Dis 1966; 8: 29-54.
15. Bienzel U, Ebert F, Dietrich M. Cutaneous leishmaniasis in Eastern Saudi Arabia. Epidemiological and clinical features in a non-immune population living in an endemic area. Tropenmed Parasitol 1978; 29: 188-193.
16. Killick-Kendrick R, Bryceson AD, Peters W, Evans DA, Leaney AJ, Rioux JA. Zoonotic cutaneous leishmaniasis in Saudi Arabia: Lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major. Trans R Soc Trop Med Hyg 1985; 79: 363-365.
17. Al-Jasser MH. Drug sensitivity of cutaneous leishmaniasis in Al Kharj, Saudi Arabia. Thesis submitted for PhD. Faculty of Medicine, University of London, 1995. p. 115-133.
18. Griffiths WAD. Old World cutaneous leishmaniasis. In: Peters W, Killick-Kendrick, R, editors. The leishmaniasis in Biology and Medicine. Vol. II. London: Academic Press; 1987. p. 617-663.
19. Al-Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int J Infec Dis 2004; 8: 244-250.
20. Dye C, Killick-Kendrick R, Ben Ismael R, Al-Gindan Y. Zoonotic cutaneous leishmaniasis in Saudi Arabia: results of a preliminary epidemiological survey in Al-Ihsa oasis. Trans R Soc Trop Med Hyg 1989; 83: 493-498.
21. Wortman G, Miller SR, Oster C, Jackson J, Aronson N. A randomized, double-blind study of the efficacy of a 10 or 20 day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States Military personnel. Clin Infec Dis 2002; 35: 261-267.
22. Ashford RW. The leishmaniasis as emerging and reemerging zoonoses. Int J Parasitol 2000; 30: 1269-1281.
23. Ashford RW, Desjeux P, Deraadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 1992; 8: 104-105.
24. Grogle M, Gasser Jr RA, Magill AJ, Johnson SC, Oster CV. Leishmaniasis in U. S. rangers and marines associated with jungle warfare training in French Guina during 1992-1993. Proceeding of the Joint Meeting of the American Society of Tropical Medicine and Hygiene and American Society of Parasitology. Abstract #619. Atlanta, Georgia. USA: 1993. p. 377.
25. Al-Dafas AA, Mohamed CK. The Epidemiology of cutaneous leishmaniasis in ARAMCO health care population. Proceeding of the Medical Symposium in Leishmanaisis. 1980 March 22-24; Dammam, KSA; Ministry of Health: p. 147-160.
26. World Health Organization. The World Health Report. Geneva: WHO; 2002. p. 192-197.
27. Al-Zahrani MA, Al-Tiwaigri AS, AL-Shamry FG, Alfaki IA. Epidemiological, chemical and immunological studies of visceral leishmaniasis in Southwest Saudi region of the Kingdom of Saudi Arabia. Riyadh, (KSA): MOH; 1993.
28. Berman J. Recent development in Leishmaniasis: Epidemiology, Diagnosis and Treatment. Curr Infec Dis Rep 2005; 7: 33-38.
29. Croft SL. Recent development in the chemotherapy of leishmaniasis. Trends Pharmacol Sci 1988; 9: 376-381.
30. Allen S, Neal RA. The in vitro susceptibility of macrophages infected with amastigotes of Leishmania spp., to pentavalent antimonial drugs and other compounds with special relevance to cutaneous isolates. In: Hart DT, editor. Leishmaniasis: the current status and new strategies for control. New York: Plenum Press; 1989. p. 711-720.
31. Bryceson AD, Chulay JD, Ho M, Mugambii M, Were JB, Muigai R, et al. Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies. Trans R Soc Trop Med Hyg 1985; 79: 700-704.
32. Al-Jaser MH, El-Yazigi A, Croft SL. Pharmacokinetics of antimony in patients treated with Sodium Stibogluconate for cutaneous leishmaniasis. Pharmaceutical Research 1995; 12: 113-116.
33. Croft SL. Field epidemiology. Drug sensitivity of leishmania species: some unresolved problems. Trans R Soc Trop Med Hyg 2002; 96 (supp 1): S1/27-S1/29.
34. Davies CR, Kaye P, Croft SL, Sundar S. Leishmaniasis: new approaches to disease control. BMJ 2003; 326: 377-382.